These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 26454060)

  • 1. Protease inhibitor monotherapy is effective in controlling human immunodeficiency virus 1 shedding in the male genital tract.
    Torres-Cornejo A; BenMarzouk-Hidalgo OJ; Viciana P; Sánchez B; López-Ruz MA; López-Cortés LF; Gutiérrez-Valencia A
    Clin Microbiol Infect; 2016 Jan; 22(1):98.e7-98.e10. PubMed ID: 26454060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of protease inhibitor therapy on human immunodeficiency virus type 1 levels in semen (AIDS clinical trials group protocol 850).
    Eron JJ; Smeaton LM; Fiscus SA; Gulick RM; Currier JS; Lennox JL; D'Aquila RT; Rogers MD; Tung R; Murphy RL
    J Infect Dis; 2000 May; 181(5):1622-8. PubMed ID: 10783117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genital secretion HIV RNA shedding in HIV-positive patients on ritonavir-boosted protease inhibitor monotherapy or standard combination ART: a cross-sectional sub-study from the PIVOT Trial.
    Arenas-Pinto A; Stöhr W; Khoo S; Clarke A; Beeching N; Warwick Z; Lee V; Else L; Wiggins R; Ferns B; Nastouli E; Dunn D; Lacey CJ; Paton NI;
    Antivir Ther; 2020; 25(1):55-59. PubMed ID: 32202510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of HIV-1 shedding in male genital tract after 1 year of first-line lopinavir/ritonavir alone or in combination with zidovudine/lamivudine.
    Ghosn J; Chaix ML; Peytavin G; Bresson JL; Galimand J; Girard PM; Raffi F; Cohen-Codar I; Delfraissy JF; Rouzioux C
    J Antimicrob Chemother; 2008 Jun; 61(6):1344-7. PubMed ID: 18343806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 p24 and CD4
    Benmarzouk-Hidalgo OJ; Torres-Cornejo A; Gutierrez-Valencia A; Viciana P; López-Cortés LF
    Enferm Infecc Microbiol Clin; 2017 Mar; 35(3):174-178. PubMed ID: 26976380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Viral Dynamics in Semen During Early HIV Infection.
    Morris SR; Zhao M; Smith DM; Vargas MV; Little SJ; Gianella S
    Clin Infect Dis; 2017 Feb; 64(4):428-434. PubMed ID: 28174909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent HIV RNA shedding in semen despite effective antiretroviral therapy.
    Sheth PM; Kovacs C; Kemal KS; Jones RB; Raboud JM; Pilon R; la Porte C; Ostrowski M; Loutfy M; Burger H; Weiser B; Kaul R;
    AIDS; 2009 Sep; 23(15):2050-4. PubMed ID: 19710596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1-RNA in seminal plasma correlates with detection of HIV-1-DNA in semen cells, but not with CMV shedding, among MSM on successful antiretroviral regimens.
    Gantner P; Assoumou L; Leruez-Ville M; David L; Suzan-Monti M; Costagliola D; Rouzioux C; Ghosn J;
    J Antimicrob Chemother; 2016 Nov; 71(11):3202-3205. PubMed ID: 27432601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shedding of HIV and human herpesviruses in the semen of effectively treated HIV-1-infected men who have sex with men.
    Gianella S; Smith DM; Vargas MV; Little SJ; Richman DD; Daar ES; Dube MP; Zhang F; Ginocchio CC; Haubrich RH; Morris SR;
    Clin Infect Dis; 2013 Aug; 57(3):441-7. PubMed ID: 23595831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The danish protease inhibitor study: a randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infection.
    Katzenstein TL; Kirk O; Pedersen C; Lundgren JD; Nielsen H; Obel N; Nielsen C; Mathiesen LR; Gerstoft J
    J Infect Dis; 2000 Sep; 182(3):744-50. PubMed ID: 10950767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pig-tailed macaques infected with human immunodeficiency virus (HIV) type 2GB122 or simian/HIV89.6p express virus in semen during primary infection: new model for genital tract shedding and transmission.
    Pullium JK; Adams DR; Jackson E; Kim CN; Smith DK; Janssen R; Gould K; Folks TM; Butera S; Otten RA
    J Infect Dis; 2001 Apr; 183(7):1023-30. PubMed ID: 11237826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Simian Immunodeficiency Virus in Semen, Urethra, and Male Reproductive Organs during Efficient Highly Active Antiretroviral Therapy.
    Matusali G; Dereuddre-Bosquet N; Le Tortorec A; Moreau M; Satie AP; Mahé D; Roumaud P; Bourry O; Sylla N; Bernard-Stoecklin S; Pruvost A; Le Grand R; Dejucq-Rainsford N
    J Virol; 2015 Jun; 89(11):5772-87. PubMed ID: 25833047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy.
    Zhang H; Dornadula G; Beumont M; Livornese L; Van Uitert B; Henning K; Pomerantz RJ
    N Engl J Med; 1998 Dec; 339(25):1803-9. PubMed ID: 9854115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of antiretroviral therapy duration and intensification on isolated shedding of HIV-1 RNA in semen.
    Osborne BJ; Sheth PM; Yi TJ; Kovacs C; Benko E; Porte Cl; Huibner S; Le AQ; Danroth R; Baraki B; Mazzulli T; Brumme ZL; Kaul R
    J Infect Dis; 2013 Apr; 207(8):1226-34. PubMed ID: 23329849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seminal HIV-1 RNA Detection in Heterosexual African Men Initiating Antiretroviral Therapy.
    Mujugira A; Coombs RW; Heffron R; Celum C; Ronald A; Mugo N; Baeten JM;
    J Infect Dis; 2016 Jul; 214(2):212-5. PubMed ID: 27053765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for HIV-1 shedding in semen.
    Speck CE; Coombs RW; Koutsky LA; Zeh J; Ross SO; Hooton TM; Collier AC; Corey L; Cent A; Dragavon J; Lee W; Johnson EJ; Sampoleo RR; Krieger JN
    Am J Epidemiol; 1999 Sep; 150(6):622-31. PubMed ID: 10490002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review.
    Bierman WF; van Agtmael MA; Nijhuis M; Danner SA; Boucher CA
    AIDS; 2009 Jan; 23(3):279-91. PubMed ID: 19114854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seminal shedding of human immunodeficiency virus type 1 and human cytomegalovirus: evidence for different immunologic controls.
    Krieger JN; Coombs RW; Collier AC; Ross SO; Speck C; Corey L
    J Infect Dis; 1995 Apr; 171(4):1018-22. PubMed ID: 7706780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: clinical correlations.
    Lafeuillade A; Solas C; Halfon P; Chadapaud S; Hittinger G; Lacarelle B
    HIV Clin Trials; 2002; 3(1):27-35. PubMed ID: 11819183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal HIV-1 shedding among HIV-1 infected women in the current era of combined antiretroviral therapy: A cross sectional study.
    Grignolo S; Bruzzone B; Gabbi L; Gerbaldo D; Gallo F; Nigro N; Icardi G; Viscoli C; Di Biagio A
    Virulence; 2017 Jan; 8(1):101-108. PubMed ID: 27459346
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.